|Print Page | Close Window|
|November 24, 2015 - 5:01 p.m.|
Gilead Sciences to Present at Two Upcoming Investor Conferences on Tuesday, December 1
|November 23, 2015 - 6:36 a.m.|
European Commission Grants Marketing Authorization for Gilead’s Single Tablet Regimen Genvoya® (Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide) for the Treatment of HIV-1 Infection
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.